Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
  • Users Online: 3583
  • Home
  • Print this page
  • Email this page

From Biologics to Biosimilars and Biobetters - Democratization of High-end Therapeutics

“Would you tell me, please, which way I ought to go from here?” - Alice; “That depends a good deal on where you want to get to.” - The Cheshire Cat -Lewis Carroll, Alice...

[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Current perspectives on use of anti-vascular endothelial growth factor agents for retinal disorders

The introduction of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents has lead to paradigm shifts in management of retinal disorders of various etiologies. We have come a long ...

[Abstract] | [HTML Full text] | [PDF] |

Albrecht von Graefe and the foundation of scientific ophthalmology

[INLINE:1] Albrecht von Graefe is considered one of the founding fathers of modern ophthalmology. On his 150th death anniversary, we intend to remember his career and accomplishments, and his contr...

[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]

Current Issue

Pubmed

Current Issue

February 2021 | Vol 69 | Issue 2

Editorial

From Biologics to Biosimilars and Biobetters - Democratization of High-end Therapeutics

“Would you tell me, please, which way I ought to go from here?” - Alice; “That depends a good deal on where you want to get to.” - The Cheshire Cat -Lewis Carroll, Alice...


Guest Editorial

Current perspectives on use of anti-vascular endothelial growth factor agents for retinal disorders

The introduction of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents has lead to paradigm shifts in management of retinal disorders of various etiologies. We have come a long ...


Tales of Yore

Albrecht von Graefe and the foundation of scientific ophthalmology

[INLINE:1] Albrecht von Graefe is considered one of the founding fathers of modern ophthalmology. On his 150th death anniversary, we intend to remember his career and accomplishments, and his contr...


One Minute Ophthalmology

A Jelly cyst - Keep your mind ticking

Case An 8-year-old boy presented with diminution of vision in left eye (OS) following firecracker injury 3 days back. There were no previous ocular or systemic complaints. The best c...


View All Articles

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data

The journal is indexed with, or included in, the following:
DOAJ, EMBASE/ Excerpta Medica, Indian Science Abstracts, IndMed, MEDLINE/Index Medicus, PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded, Web of Science

Impact Factor as reported in the 2019 Journal Citation Reports (Clarivate Analytics, 2020): 1.25

About IJO
  • The Indian Journal of Ophthalmology (ISSN 0301-4738) or IJO, is the official scientific journal of the All India Ophthalmological Society (AIOS), which at a membership strength of over 15000 is probably the 2nd largest society of ophthalmologists in the world. The IJO which is an indexed, peer reviewed journal, originated as a platform for the scientific expression of the AIOS which is the umbrella society to which almost all ophthalmologists in India belong. However it has grown over the years to be international in its scope, also accepting articles of merit from contributors all over the world. IJO now in its Diamond Jubilee Year is published Monthly.
Submit Article Subscribe Most Popular Articles Join as Reviewer Email Alerts Recommend this journal to your library or friends